Theriva Biologics, Inc. (TOVX)
NYSEAMERICAN: TOVX · IEX Real-Time Price · USD
0.418
+0.012 (2.96%)
May 2, 2024, 4:00 PM EDT - Market closed

Theriva Biologics Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.
Year Current2023202220212020201920182017201620152014 2013 - 2006
Market Capitalization
777368986570208106
Upgrade
Market Cap Growth
-1.72%-79.95%369.37%-10.11%12.82%-88.44%-7.08%-66.20%96.43%54.96%
Upgrade
Enterprise Value
-14-14-33-302-6-21485118788
Upgrade
PE Ratio
-0.40-0.40-0.36-1.55-0.61-0.53-0.30-2.95-2.58-4.75-5.35
Upgrade
PB Ratio
0.190.200.140.55-1.614.680.44-43.6618.2812.9611.08
Upgrade
P/FCF Ratio
-0.38-0.38-0.38-2.79-0.63-0.61-0.44-3.20-2.47-5.28-6.56
Upgrade
P/OCF Ratio
-0.39-0.39-0.38-2.79-0.63-0.61-0.44-3.23-2.52-5.35-6.58
Upgrade
EV/EBITDA Ratio
0.710.711.582.11-0.190.391.63-3.23-1.89-4.29-4.47
Upgrade
EV/EBIT Ratio
0.690.691.562.09-0.190.381.60-3.18-1.88-4.28-4.47
Upgrade
EV/FCF Ratio
0.720.721.722.31-0.160.421.24-2.36-1.80-4.75-5.48
Upgrade
Debt / Equity Ratio
0.060.060.030.02-0.100.40-----
Upgrade
Debt / EBITDA Ratio
-0.11-0.11-0.08-0.11-0.05-0.05-----
Upgrade
Debt / FCF Ratio
-0.11-0.11-0.09-0.12-0.04-0.05-----
Upgrade
Quick Ratio
3.453.455.9318.942.102.858.551.750.961.341.83
Upgrade
Current Ratio
4.074.076.4519.382.683.118.721.831.091.951.99
Upgrade
Return on Equity (ROE)
-42.90%-42.90%-33.80%-31.50%315.80%-212.30%-2762.50%-7941.20%-1376.30%-656.90%-238.90%
Upgrade
Return on Assets (ROA)
-29.30%-29.30%-24.90%-30.70%-135.50%-72.60%-163.60%-117.20%-156.10%-176.70%-173.10%
Upgrade
Return on Capital (ROIC)
-54.79%-54.79%-40.33%-21.33%236.61%-615.93%-102.95%1754.75%-1020.86%-255.31%-214.55%
Upgrade
Earnings Yield
-255.99%-250.32%-277.90%-64.52%-163.98%-188.70%-334.93%-33.89%-38.77%-21.03%-18.69%
Upgrade
FCF Yield
-267.83%-261.91%-266.42%-35.90%-159.02%-162.84%-228.92%-31.26%-40.50%-18.94%-15.23%
Upgrade
Buyback Yield / Dilution
-5.09%-5.09%-25.76%-541.06%-15.65%-163.75%-75.40%-31.90%-16.83%-30.28%-35.64%
Upgrade
Total Shareholder Return
-5.09%-5.09%-25.76%-541.06%-15.65%-163.75%-75.40%-31.90%-16.83%-30.28%-35.64%
Upgrade
Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).